Dr. Karen Blitz-Shabbir, DO

Neurology Brooklyn, NY Female
NPI: 1275562894
Total Payments
$393,441
2024 Payments
$1,855
Companies
40
Transactions
978
Medicare Patients
1,235
Medicare Billing
$158,700

Payment Breakdown by Category

Other$233,838 (59.4%)
Consulting$104,878 (26.7%)
Travel$30,787 (7.8%)
Food & Beverage$23,140 (5.9%)
Education$798.80 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $233,838 128 59.4%
Consulting Fee $104,878 32 26.7%
Travel and Lodging $30,787 118 7.8%
Food and Beverage $23,140 686 5.9%
Education $798.80 14 0.2%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $248,183 453 $0 (2024)
Genentech USA, Inc. $38,089 59 $0 (2024)
Celgene Corporation $37,184 75 $0 (2024)
Alexion Pharmaceuticals, Inc. $19,911 43 $0 (2021)
Teva Pharmaceuticals USA, Inc. $16,147 88 $0 (2024)
Acorda Therapeutics, Inc $9,337 25 $0 (2019)
GENZYME CORPORATION $9,174 33 $0 (2019)
EMD Serono, Inc. $6,848 33 $0 (2024)
E.R. Squibb & Sons, L.L.C. $4,800 4 $0 (2022)
ABBVIE INC. $818.39 50 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,855 51 Biogen, Inc. ($599.75)
2023 $8,776 53 Genentech USA, Inc. ($6,792)
2022 $21,152 51 Biogen, Inc. ($16,565)
2021 $15,649 31 Biogen, Inc. ($11,590)
2020 $53,679 74 Biogen, Inc. ($29,816)
2019 $106,894 173 Biogen, Inc. ($62,111)
2018 $99,960 237 Biogen, Inc. ($74,644)
2017 $85,478 308 Biogen, Inc. ($51,589)

All Payment Transactions

978 individual payment records from CMS Open Payments — Page 1 of 40

Date Company Product Nature Form Amount Type
12/18/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $31.93 General
Category: NEUROSCIENCE
12/18/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $6.56 General
Category: BOTOX THERAPEUTIC
12/16/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $94.08 General
12/12/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $12.73 General
Category: BOTOX THERAPEUTIC
12/06/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $18.32 General
Category: BOTOX THERAPEUTIC
11/20/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $13.13 General
Category: BOTOX THERAPEUTIC
10/31/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $6.67 General
Category: BOTOX THERAPEUTIC
10/16/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.91 General
Category: Neuroscience
10/14/2024 Biogen, Inc. TYSABRI (Biological) Food and Beverage In-kind items and services $115.24 General
Category: Neurology
10/14/2024 Biogen, Inc. TYSABRI (Biological) Food and Beverage In-kind items and services $26.65 General
Category: Neurology
10/10/2024 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage Cash or cash equivalent $120.15 General
Category: Neurology
10/02/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $19.19 General
Category: BOTOX THERAPEUTIC
09/30/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $25.35 General
Category: Immunology
09/30/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $3.70 General
Category: Immunology
09/30/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $0.84 General
Category: Immunology
09/18/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.65 General
Category: Neuroscience
09/09/2024 Biogen, Inc. QALSODY (Drug), SKYCLARYS Food and Beverage In-kind items and services $12.95 General
Category: Neurology
08/08/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $21.10 General
Category: Inflammation/Rare Disease
08/01/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $16.93 General
Category: BOTOX THERAPEUTIC
07/30/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $85.74 General
Category: Immunology
07/24/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $10.38 General
Category: BOTOX THERAPEUTIC
07/11/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $149.78 General
07/11/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $10.04 General
Category: BOTOX THERAPEUTIC
06/13/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $7.45 General
Category: BOTOX THERAPEUTIC
06/10/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $17.76 General
Category: Neuroscience
123…40»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 416 485 $208,808 $52,092
2022 7 328 380 $162,134 $40,235
2021 9 278 326 $153,442 $39,360
2020 10 213 264 $119,550 $27,013
Total Patients
1,235
Total Services
1,455
Medicare Billing
$158,700
Procedure Codes
38

All Medicare Procedures & Services

38 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 96 132 $54,252 $14,666 27.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 69 69 $43,815 $9,697 22.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 69 95 $26,315 $7,738 29.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 49 49 $25,578 $5,672 22.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 35 35 $26,985 $5,247 19.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 32 33 $18,381 $5,180 28.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 44 49 $7,203 $2,265 31.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 22 23 $6,279 $1,627 25.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 72 94 $38,634 $11,398 29.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 47 47 $29,845 $7,333 24.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 37 38 $29,298 $6,823 23.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 21 23 $12,811 $3,868 30.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 34 39 $10,803 $3,431 31.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 34 35 $14,385 $2,055 14.3%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 37 54 $7,938 $1,938 24.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 18 21 $5,733 $1,416 24.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 13 13 $8,255 $1,132 13.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 15 16 $4,432 $840.97 19.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 44 44 $33,924 $8,398 24.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 47 60 $26,004 $7,184 27.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 36 48 $26,976 $6,995 25.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 29 29 $18,415 $4,721 25.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 29 33 $9,141 $2,843 31.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 14 14 $11,158 $2,716 24.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 18 18 $9,396 $2,216 23.6%
12»

About Dr. Karen Blitz-Shabbir, DO

Dr. Karen Blitz-Shabbir, DO is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275562894.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Blitz-Shabbir, DO has received a total of $393,441 in payments from pharmaceutical and medical device companies, with $1,855 received in 2024. These payments were reported across 978 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($233,838).

As a Medicare-enrolled provider, Blitz-Shabbir has provided services to 1,235 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $158,700. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Brooklyn, NY
  • Active Since 07/03/2006
  • Last Updated 12/08/2022
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1275562894

Products in Payments

  • TECFIDERA (Drug) $98,182
  • TYSABRI (Biological) $55,637
  • OCREVUS (Biological) $23,266
  • Ozanimod (Drug) $22,064
  • COPAXONE (Drug) $15,133
  • ZEPOSIA (Drug) $15,120
  • VUMERITY (Drug) $13,419
  • AMPYRA (Drug) $9,322
  • LEMTRADA (Drug) $8,894
  • Non-Covered Product (Drug) $7,840
  • Ocrevus (Biological) $6,856
  • Soliris (Drug) $2,579
  • GILENYA (Drug) $480.66
  • Mavenclad (Drug) $463.66
  • Mavenclad (Biological) $453.54
  • BOTOX (Biological) $448.66
  • AJOVY (Drug) $368.61
  • AUBAGIO (Drug) $279.69
  • MAVENCLAD (Drug) $262.77
  • UBRELVY (Drug) $214.38

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Brooklyn

Miss. Larisa Syrow, Md, MD

Neurology — Payments: $182,526

Neurology $182,526

Nada Abou-Fayssal, Md, MD

Neurology — Payments: $126,065

Neurology $126,065

Robyn Wolintz, Md, MD

Neurology — Payments: $123,772

Neurology $123,772

Miran Salgado, Md, MD

Neurology — Payments: $101,072

Neurology $101,072

Dr. Dmitriy Grinshpun, M.d, M.D

Neurology — Payments: $96,680

Neurology $96,680

Dr. Daryl Victor, M.d, M.D

Neurology — Payments: $60,707

Neurology $60,707